1. Home
  2. BNR vs DH Comparison

BNR vs DH Comparison

Compare BNR & DH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Burning Rock Biotech Limited

BNR

Burning Rock Biotech Limited

HOLD

Current Price

$9.36

Market Cap

76.5M

Sector

Health Care

ML Signal

HOLD

Logo Definitive Healthcare Corp.

DH

Definitive Healthcare Corp.

HOLD

Current Price

$0.86

Market Cap

89.9M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
BNR
DH
Founded
2014
2011
Country
China
United States
Employees
N/A
N/A
Industry
Medical Specialities
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
76.5M
89.9M
IPO Year
2019
2021

Fundamental Metrics

Financial Performance
Metric
BNR
DH
Price
$9.36
$0.86
Analyst Decision
Hold
Analyst Count
0
5
Target Price
N/A
$3.08
AVG Volume (30 Days)
20.8K
571.4K
Earning Date
06-05-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
63.28
EPS
N/A
N/A
Revenue
N/A
$241,521,000.00
Revenue This Year
$111.65
N/A
Revenue Next Year
N/A
$0.74
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.51
$0.62
52 Week High
$41.72
$4.70

Technical Indicators

Market Signals
Indicator
BNR
DH
Relative Strength Index (RSI) 51.80 54.48
Support Level $8.05 $0.80
Resistance Level $13.89 $1.04
Average True Range (ATR) 0.85 0.08
MACD 0.55 0.01
Stochastic Oscillator 90.32 84.82

Price Performance

Historical Comparison
BNR
DH

About BNR Burning Rock Biotech Limited

Burning Rock Biotech Ltd is a cancer diagnostics company. The Group provides pharma research and development services, mainly cancer therapy selection tests services, companion diagnostics development services, and other service agreements with the combination of various customized tests services and analytical validation services, to pharmaceutical companies for developing new drugs for targeted therapies, immunotherapies on various types of cancers, and to hospitals for their studies on cancer diagnosis & treatment. It had three operating segments, including the Central laboratory business, the In-hospital business, & Pharma research & development services. It generates the majority of its revenue from the Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, & others.

About DH Definitive Healthcare Corp.

Definitive Healthcare Corp is a provider of healthcare commercial intelligence. Its SaaS-based healthcare commercial intelligence platform is designed to provide comprehensive and accurate information on the healthcare ecosystem in the U.S. The platform uses deep analytics and data science to help customers develop data-driven strategic decisions, such as finding new markets to enter, building comprehensive go-to-market strategies, accessing tactical information to help target the right decision makers, and improving win rates with detailed contextual information. The company derives substantially all of its revenue from the sale of subscription fees for access to its platform and stand-ready support. Geographically, it derives a majority of its revenue from the United States.

Share on Social Networks: